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ABSTRACT
There is a frequent association between aortic valve stenosis 
and gastrointestinal bleeding, also known as Heyde’s syn-
drome. The pathophysiologic basis for this syndrome seems 
to be an acquired von Willebrand factor deficiency, leading 
to bleeding of angiodysplastic arteriovenous malformations. 
Treatment options include the location and cauterization of 
bleeding points, which is associated to high recurrence rates. 
Valve replacement appears to offer the best hope of long-term 
resolution of bleeding, and should be considered in most 
cases. We report a 79 year-old patient with aortic stenosis 
and gastrointestinal bleeding due to duodenal angiodysplasia 
treated by transcatheter aortic valve implantation.
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RESUMO
Sangramento Gastrintestinal por Angiodisplasia  
e Estenose Aórtica: Síndrome de Heyde
Existe uma associação frequente entre estenose valvar aórtica e 
sangramento gastrintestinal, também conhecida como síndrome 
de Heyde. A base fisiopatológica dessa síndrome parece ser 
uma deficiência adquirida do fator de von Willebrand, que 
leva ao sangramento de malformações arteriovenosas angio-
displásicas. As alternativas de tratamento incluem a localização 
de pontos de sangramento e a cauterização, mas tal opção 
terapêutica está associada a alta recorrência. A substituição 
da válvula parece oferecer a melhor esperança de resolução 
a longo prazo do sangramento e deve ser considerada na 
maioria das vezes. Relatamos aqui o caso de uma paciente 
de 79 anos com estenose aórtica e sangramento gastrintes-
tinal devido à angiodisplasia duodenal, tratada por implante 
transcateter de válvula aórtica.
DESCRITORES: Estenose da valva aórtica. Hemorragia gastroin-
testinal. Angiodisplasia. Implante de prótese de valva cardíaca.
H eyde’ssyndrome, an association between aortic stenosis and gastrointestinal bleeding, was first described by Edward Heyde in 1958,1 in a series 
of ten patients with aortic stenosis and gastrointestinal 
bleeding of unknown cause, and the association with 
intestinal angiodysplasia was only established subse-
quently. Gastrointestinal bleeding appears to be caused 
by acquired von Willebrand disease type 2A, character-
ized by a reduction in high molecular weight multimers 
of von Willebrand factor (VWF). These multimers are 
important to maintain hemostasis in situations of high 
shear stress – predominant flow conditions in patients 
with angiodysplastic lesions.2 Valve replacement ap-
pears to offer the best hope for a long-term resolution 
of bleeding, and should beconsidered in most cases.3 
The case of a patient with severe aortic stenosis and 
gastrointestinal bleeding due to duodenal angiodysplasia 
is reported, successfully treated by transcatheter aortic 
valve implantation.
CASE REPORT
Female patient, 79 years, with severe aortic stenosis 
(valve area of 0.6 cm²; maximum transvalvular gradient 
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was discharged to be followed by her cardiologist in 
good clinical conditions, with hemoglobin of 8.2 g/dL, 
21 days after admission. She was using acetylsalicylic 
acid (ASA) 100 mg/day and clopidogrel 75 mg/day was 
prescribed (dual antiplatelet therapy), after the absence 
of intestinal bleeding recurrence was confirmed, seven 
days after discharge.
DISCUSSION
Intestinal angiodysplasia and aortic stenosis are 
usually asymptomatic chronic–degenerative diseases, 
whose prevalence increases with age. Both are asso-
ciated with cardiovascular risk factors. Many studies 
suggest that there is a greater occurrence of intestinal 
stenosis in subjects with aortic angiodysplasia, and 
vice versa.4 The main concept behind this association 
is based on the fact that both angiodysplasia intestinal 
and aortic stenosis are related to the physiological 
processes of aging.5
In 1992, an etiopathogenic mechanism was proposed 
by Warkentin et al.,2 according to which the acquired 
deficiency of high molecular weight multimers of VWF 
(von Willebrand disease type 2A), necessary to main-
tain hemostasis in high-flow conditions,4 as occurs in 
arteriovenous angiodysplastic malformations, appeared 
to be the connection between the two components 
of this syndrome. The VWF is secreted by endothelial 
cells into the blood, contributing to platelet thrombus 
formation and acting as a mediator of platelet adhe-
sion at the site of vascular injury.6 The high shear stress 
caused by the stenotic valve results in changes in the 
VWF5 molecule structure and subsequent proteolysis 
of the high molecular weight multimers by ADAMTS13 
enzyme. The multimers with reduced size are, from 
the hemostatic point of view, less competent than the 
intact large multimers. This hypothesis is supported by 
the fact that the change of the stenotic aortic valve 
results in long–term resolution of digestive bleeding. 
In summary, the development of the acquired von Wil-
lebrand disease type 2A due to aortic stenosis causes 
hemostatic abnormalities, which predispose to intestinal 
angiodysplastic bleeding, previously subclinical.5
A study by Vincentelli et al.7 demonstrated that the 
degree of aortic stenosis is proportional to hemostatic 
changes: the higher the gradient pressure, the lower the 
availability of high molecular weight multimers. In this 
study, the aortic valve replacement ceased the depletion 
of these multimers, and this effect has been observed 
in some patients as soon as the first postoperative day.5
Regarding gastrointestinal bleeding due to intestinal 
angiodysplasia, the options for treatment include the 
location and cauterization of lesions; however, these 
strategies are associated with high rate of recurrence. 
The improvement in hematological alterations after 
aortic valve replacement has been described and is also 
accompanied by clinical improvement: this approach 
of 96 mmHg and mean of 59 mmHg; and preserved 
left ventricular systolic function) was hospitalized for 
symptomatic heart failure associated with melena. On 
admission, hemoglobin level was 4.6 g/dL. She was 
initially submitted to endoscopic gastrointestinal tract 
assessment, which showed no alterations, and colonos-
copy, which showed diverticular disease of the colon, 
with no evidence of recent bleeding. After receiving 
transfusion of packed red blood cells, she achieved 
partial symptom improvement.
After the case study, it was decided to perform the 
transcatheter aortic stenosis treatment. A 23-mm Edwards 
SAPIEN XT valve (Edwards Life Sciences – Irvine, USA) 
was implanted by transfemoral route. The procedure 
was successfully performed without complications, 
resulting in aortic transvalvular gradient of 10  mmHg 
with no significant aortic regurgitation (Figure 1). Two 
days after the procedure, there was recurrence of 
melena. At that time, it was decided to evaluate the 
small bowel by enteroscopy, for clarification of the 
bleeding site. The enteroscopy evaluated the bowel 
up to the medium jejunum, showing angiodysplastic 
lesion in the proximal duodenum (Figure 2), which was 
cauterized with an argon plasma catheter. The patient 
Figure 1 – (A) Release of Edwards SAPIEN XT valve after inflating the 
balloon catheter. (B) Implanted aortic valve.
Figure 2 – Angiodysplastic lesion in the proximal duodenum.
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seems to offer the best prospects for long-term resolution 
of bleeding and should be considered in most cases, 
especially those with symptomatic aortic stenosis. For 
patients at high surgical risk, in which no bleeding point 
was identified, the treatment of anemia with regular 
blood transfusions can provide some symptomatic relief.4
Aortic valve replacement appears to reduce the risk 
of gastrointestinal hemorrhage in patients with Heyde’s 
syndrome, resolving the condition in approximately 
80% of cases. Although the rates of bleeding recur-
rence are not significantly different between biological 
and mechanical valves, the increased risk of bleeding 
in patients receiving anticoagulants makes biological 
valves the choice for most patients.8 Bleeding recurrence 
occurs only when the physiopathological mechanism 
is restored, either by aortic restenosis or by patient-
prosthesis mismatch (effective valvearea/bodysurface   
< 0.85  cm2/m2 on echocardiography), with elevated 
gradients persisting postoperatively even with normal 
functioning valves.7
This case report is the second article that addresses 
the percutaneous treatment of aortic stenosis in patients 
with Heyde’s syndrome.9 Godino et al.9 reported that 
this syndrome was present in 1.7% of 400 patients un-
dergoing transcatheter aortic valve implantationat their 
institution, and that the recurrence of gastrointestinal 
bleeding was abolished in all successfully treated patients.
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